Comparison of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness Values Using Spectral-Domain and Swept-Source OCT.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 06 2022
Historique:
entrez: 29 6 2022
pubmed: 30 6 2022
medline: 2 7 2022
Statut: ppublish

Résumé

To compare peripapillary retinal nerve fiber layer (pRNFL) and macular ganglion cell-inner plexiform layer (mGCIPL) thickness measurements obtained with spectral domain optical coherence tomography (SD-OCT) and swept-source OCT (SS-OCT) using an OCT-angiography scanning protocol, and their ability to distinguish among patients with glaucoma, glaucoma suspects (GS), and healthy controls (HC). Cross-sectional study of 196 eyes (81 glaucoma, 48 GS, and 67 HC) of 119 participants. Participants underwent peripapillary and macular OCT with SD-OCT and SS-OCT. Parameters of interest were average and sector-wise pRNFL and mGCIPL thickness. Inter-device agreement was investigated with Bland-Altman statistics. Conversion formulas were developed with linear regression. Diagnostic performances were evaluated with area under the receiver operating characteristic curves. Both SD-OCT and SS-OCT detected a significant pRNFL and mGCIPL thinning in glaucoma patients compared to HC and GS for almost all study sectors. A strong linear relationship between the two devices was present for all quadrants/sectors (R2 ≥ 0.81, P < 0.001), except for the nasal (R2 = 0.49, P < 0.001) and temporal (R2 = 0.62, P < 0.001) pRNFL quadrants. SD-OCT and SS-OCT measurements had a proportional bias, which could be removed with conversion formulas. Overall, the two devices showed similar diagnostic abilities. Thickness values obtained with SD-OCT and SS-OCT are not directly interchangeable but potentially interconvertible. Both devices have a similar ability to discriminate glaucoma patients from GS and healthy subjects. OCT-Angiography scans can be reliably used to obtain structural metrics in glaucoma patients.

Identifiants

pubmed: 35767273
pii: 2783444
doi: 10.1167/tvst.11.6.27
pmc: PMC9251790
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27

Références

Invest Ophthalmol Vis Sci. 2014 Apr 29;55(6):3439-46
pubmed: 24781941
Biometrics. 1997 Jun;53(2):567-78
pubmed: 9192452
Ophthalmology. 2005 Mar;112(3):391-400
pubmed: 15745764
Ophthalmology. 2020 Aug;127(8):1043-1052
pubmed: 32085875
Br J Ophthalmol. 2014 Jul;98 Suppl 2:ii15-9
pubmed: 24357497
Can J Ophthalmol. 2009 Jun;44(3):297-307
pubmed: 19491986
Br J Ophthalmol. 2020 Dec;104(12):1710-1716
pubmed: 32122913
J Glaucoma. 2000 Feb;9(1):34-7
pubmed: 10708229
Ophthalmology. 2019 Sep;126(9):1315-1323
pubmed: 30953743
Br J Ophthalmol. 2020 Jul;104(7):974-979
pubmed: 31585965
JAMA Ophthalmol. 2022 Apr 01;140(4):319-326
pubmed: 35201270
Br J Ophthalmol. 2009 Jun;93(6):775-81
pubmed: 19304586
Opt Express. 2009 Mar 2;17(5):3997-4003
pubmed: 19259241
J Glaucoma. 2014 Jun-Jul;23(5):299-306
pubmed: 23377582
Gastroenterol Hepatol Bed Bench. 2012 Spring;5(2):79-83
pubmed: 24834204
J Glaucoma. 2009 Mar;18(3):213-6
pubmed: 19295375
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5724-30
pubmed: 20574014
PLoS One. 2016 Jan 26;11(1):e0147964
pubmed: 26812064
Eye (Lond). 2018 Sep;32(9):1483-1492
pubmed: 29789659
Am J Ophthalmol. 2005 Jul;140(1):165-6
pubmed: 16038674
Ophthalmology. 2017 Dec;124(12S):S57-S65
pubmed: 29157363
Am J Ophthalmol. 2020 Oct;218:182-191
pubmed: 32574775
Am J Ophthalmol. 2021 Jan;221:39-47
pubmed: 32828878
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4075-83
pubmed: 20237247
J Glaucoma. 2015 Jun-Jul;24(5):e109-15
pubmed: 25517254
Am J Ophthalmol. 2004 May;137(5):863-71
pubmed: 15126151
Transl Vis Sci Technol. 2020 Nov 05;9(2):58
pubmed: 33224631
J Glaucoma. 2008 Mar;17(2):122-7
pubmed: 18344758
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5713-5722
pubmed: 29114838
Transl Vis Sci Technol. 2019 May 30;8(3):28
pubmed: 31171995
Ophthalmology. 2011 Feb;118(2):241-8.e1
pubmed: 20920824
Am J Ophthalmol. 2020 Sep;217:131-139
pubmed: 32222368
Ophthalmology. 2003 Feb;110(2):340-4
pubmed: 12578778
Invest Ophthalmol Vis Sci. 2011 Oct 21;52(11):8323-9
pubmed: 21917932
PLoS One. 2015 May 15;10(5):e0125957
pubmed: 25978420
Transl Vis Sci Technol. 2021 Dec 1;10(14):20
pubmed: 34928324
Korean J Ophthalmol. 2019 Aug;33(4):315-325
pubmed: 31389207
Arch Ophthalmol. 2005 Apr;123(4):464-70
pubmed: 15824218
Am J Ophthalmol. 2015 Mar;159(3):565-76.e2
pubmed: 25498118
Ophthalmology. 2009 Jul;116(7):1271-7
pubmed: 19395086
Ophthalmology. 2011 Jul;118(7):1334-9
pubmed: 21377735
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Yonsei Med J. 2018 Sep;59(7):887-896
pubmed: 30091323
Ophthalmology. 2012 Jun;119(6):1151-8
pubmed: 22365056
Ophthalmology. 2009 Jul;116(7):1257-63, 1263.e1-2
pubmed: 19464061
Am J Ophthalmol. 2009 Jul;148(1):148-54
pubmed: 19375690
Korean J Ophthalmol. 2016 Apr;30(2):140-7
pubmed: 27051263
Ophthalmology. 2007 Jun;114(6):1046-52
pubmed: 17210181
Ophthalmology. 2021 Jan;128(1):P71-P150
pubmed: 34933745
Eur J Ophthalmol. 2013 May-Jun;23(3):289-95
pubmed: 23225090
Br J Ophthalmol. 2014 Mar;98(3):322-8
pubmed: 24307717
Ophthalmology. 2021 Jan;128(1):e7-e8
pubmed: 32921546
J Ophthalmic Vis Res. 2014 Jan;9(1):31-7
pubmed: 24982729
Invest Ophthalmol Vis Sci. 2012 Aug 31;53(9):5912-20
pubmed: 22871835
Am J Ophthalmol. 2005 Jan;139(1):44-55
pubmed: 15652827
Br J Ophthalmol. 2023 Jan;107(1):49-55
pubmed: 34301610
PLoS One. 2018 Oct 18;13(10):e0205773
pubmed: 30335815
Arch Ophthalmol. 2009 Dec;127(12):1603-9
pubmed: 20008715

Auteurs

Alessandro Rabiolo (A)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Federico Fantaguzzi (F)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Giovanni Montesano (G)

Optometry and Visual Sciences, City, University of London, London, UK.

Maria Brambati (M)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Riccardo Sacconi (R)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Francesco Gelormini (F)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Giacinto Triolo (G)

Ophthalmology Department, Fatebenefratelli and Ophthalmic Hospital, ASST-Fatebenefratelli-Sacco, Milan, Italy.

Paolo Bettin (P)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Giuseppe Querques (G)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Francesco Bandello (F)

Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH